Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dakim is a digital health company specializing in brain fitness and cognitive stimulation programs designed to help seniors maintain brain health and delay the onset of symptoms associated with Alzheimer's disease and dementia. The company's flagship product, Dakim BrainFitness, is a clinically proven software platform that provides personalized, rigorous cognitive exercises across multiple brain domains. Used in senior living communities and by individuals at home, the program utilizes a patented technology to keep users engaged and challenged. Dakim's solutions are backed by clinical research, including studies conducted at UCLA showing significant improvements in memory and language skills among users. The company remains a leader in the cognitive health space, focusing on non-pharmacological interventions for age-related cognitive decline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dakim.